Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CAR-T Meeting 2022 | Exploring the applications of CAR-Ts beyond hematology and oncology

Michael Hudecek, MD, University of Würzburg, Würzburg, Germany, discusses the potential of engineered immune cell therapies such as chimeric antigen receptor T-cells (CAR-Ts) in fields other than hematology and oncology, namely infectious diseases, auto-immune diseases, and cardiovascular diseases. This interview took place at the EBMT-EHA 4th European CAR T-cell Meeting which was held virtually in 2022.